Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Literature DB >> 11592607

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

J Bruix¹, M Sherman, J M Llovet, M Beaugrand, R Lencioni, A K Burroughs, E Christensen, L Pagliaro, M Colombo, J Rodés.

Abstract

Entities: Disease

Mesh：

Year: 2001 PMID： 11592607 DOI： 10.1016/s0168-8278(01)00130-1

Source DB: PubMed Journal: J Hepatol ISSN： 0168-8278 Impact factor: 25.083

Keyword Cloud
Cited

× No keyword cloud information.

1152 in total

1. HCC: what's the score.

Authors: D Shouval
Journal: Gut Date: 2002-06 Impact factor: 23.059

2. Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

Authors: Fidel-David Huitzil-Melendez; Marinela Capanu; Eileen M O'Reilly; Austin Duffy; Bolorsukh Gansukh; Leonard L Saltz; Ghassan K Abou-Alfa
Journal: J Clin Oncol Date: 2010-05-10 Impact factor: 44.544

3. Functional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma.

Authors: Celia Pamela Corona-Villalobos; Vivek Gowdra Halappa; Susanne Bonekamp; John Eng; Diane Reyes; David Cosgrove; Neda Rastegar; Li Pan; Timothy M Pawlik; Ihab R Kamel
Journal: Invest Radiol Date: 2015-04 Impact factor: 6.016

4. Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm.

Authors: Mariya L Samoylova; Jennifer L Dodge; Neil Mehta; Francis Y Yao; John P Roberts
Journal: Clin Transplant Date: 2014-12-01 Impact factor: 2.863

5. Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy.

Authors: Nikolaus Kohles; Dorothea Nagel; Dietrich Jüngst; Jürgen Durner; Petra Stieber; Stefan Holdenrieder
Journal: Tumour Biol Date: 2011-09-20

Review 6. Radioembolization for primary and metastatic liver cancer.

Authors: Khairuddin Memon; Robert J Lewandowski; Laura Kulik; Ahsun Riaz; Mary F Mulcahy; Riad Salem
Journal: Semin Radiat Oncol Date: 2011-10 Impact factor: 5.934

7. Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis.

Authors: Hiroshi Sogawa; Brian Shrager; Ghalib Jibara; Parissa Tabrizian; Sasan Roayaie; Myron Schwartz
Journal: HPB (Oxford) Date: 2012-08-30 Impact factor: 3.647